Eurointervention, the official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), published preclinical data on our novel, investigational Saturn TMVR device in the article Procedural performance and healing response of a novel low-profile transseptal transcatheter mitral valve replacement system. This study assessed the acute and chronic performance of the novel Saturn TMVR system in healthy preclinical models and demonstrated that 1) transseptal delivery of this bioprosthesis is feasible and reproducible and 2) that the valve has excellent haemodynamics with favourable biocompatibility over a 150-day follow-up period in an animal model.

The full article is accessible for Eurointervention subscribers here.